Clin2
NCT07710326Likely a fitNot yet recruiting

Safety study of VV261 tablets at increasing doses

Healthy Volunteers

Treatments studied

This study tests a new medicine called VV261 in healthy volunteers. It looks at whether the medicine is safe and how the body handles it. You may be able to join if you are a healthy adult aged 18-45 and meet certain health requirements.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
16 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are between 18 and 45 years old.
  • Your body mass index (BMI) is between 19 and 26, and you weigh at least 50 kg (110 lbs) if male or 45 kg (99 lbs) if female.
  • You are in good health, with normal results on physical exams, lab tests, and heart checks.
  • You have not used any prescription or over-the-counter drugs, herbal supplements, or health products in the past 2 weeks.
  • You are willing to use effective birth control during the study and for 3 months after the last dose.
  • You have no major medical conditions, allergies, or recent blood loss or transfusions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07302269Recruiting· Phase 1
Safety study of VV261 tablets in healthy Chinese volunteers

This trial tests a new tablet called VV261 in healthy volunteers to see how safe it is and how the body processes it. It is an early study to gather important information before larger trials.

Hefei, Anhui
NCT07507838Recruiting· Early Phase 1
Safety study of VV913 capsules in healthy male volunteers

This early-phase trial tests VV913 capsules in healthy men to see how safe they are and how the body processes the drug. It may help find the right dose for future studies.

Hefei, Anhui
NCT07240636Recruiting· Phase 1
How food affects a new medicine in healthy volunteers

This trial studies how food changes the way your body processes a new medicine called VV119. It helps make sure the drug works safely and effectively. Healthy adults are needed to participate.

Hefei, Anhui
NCT07372703Recruiting· Phase 1
Safety study of VV913 capsules in healthy Chinese men

This study tests a new capsule called VV913 in healthy male volunteers to see how safe it is and how the body processes it. It is a first-in-human trial in China to gather basic safety information.

Hefei, Anhui
NCT07565792Recruiting· Phase 1
How Food Affects a New Drug in Healthy Men

This study tests how eating food changes how your body absorbs a new experimental drug called VV913. Researchers will give you the drug with and without food to see if meals make a difference in how well it works.

Hefei, Anhui
NCT07829406Not yet recruiting· Phase 1
Safety study of a new medicine in healthy adults

This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.

Salt Lake City, Utah

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.